> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Since Our Last Issue ...
- URL: https://www.fdaweb.com/since-our-last-issue-27/
- Published: 2020-09-20T12:00:00.000Z
- Updated: 2026-09-14T16:29:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141820

Molecular diagnostics company **Biodesix** has acquired Seattle-based **Integrated Diagnostics** on undisclosed terms. The transaction includes Integrated’s lead oncology product, XL2 test, which is intended to rule out cancer for patients with suspicious lung nodules.

**Becton, Dickinson and Co.** hascompleted its acquisition of **TVA Medical**, whichdevelops vascular access solutions for patients with chronic kidney disease requiring hemodialysis. The addition of TVA Medical enables BD to offer the everlinQ endoAVF System, a new endovascular arteriovenous (AV) fistula creation technology.

**Bovie Medical** has agreed to sell to **Symmetry Surgical** its core electrosurgical and cauteries business for $97 million in cash. Bovie is the developer of J-Plasma, a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue.